AIG
BHVN

American International Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

American International Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,981
Closed -$4.53M – 3064
2022
Q3 		$4.53M Buy
29,981
+824
+3% +$122K 0.03% 710
2022
Q2 		$4.25M Buy
29,157
+1,504
+5% +$192K 0.03% 760
2022
Q1 		$3.28M Sell
27,653
-1,947
-7% -$243K 0.02% 891
2021
Q4 		$4.08M Sell
29,600
-885
-3% -$113K 0.02% 863
2021
Q3 		$4.24M Buy
30,485
+211
+0.7% +$26.3K 0.02% 835
2021
Q2 		$2.94K Sell
30,274
-479
-2% -$38.9K 0.01% 969
2021
Q1 		$2.1K Sell
30,753
-286
-0.9% -$23.1K 0.01% 1093
2020
Q4 		$2.66K Buy
31,039
+2,268
+8% +$192K 0.01% 976
2020
Q3 		$1.87M Sell
28,771
-85
-0.3% -$5.57K 0.01% 977
2020
Q2 		$2.11M Buy
28,856
+3,529
+14% +$188K 0.01% 943
2020
Q1 		$862K Buy
25,327
+836
+3% +$38.2K ﹤0.01% 1174
2019
Q4 		$1.33M Sell
24,491
-207
-0.8% -$10.3K 0.01% 1187
2019
Q3 		$1.03M Buy
24,698
+3,528
+17% +$149K ﹤0.01% 1275
2019
Q2 		$927K Buy
21,170
+1,248
+6% +$70.3K ﹤0.01% 1354
2019
Q1 		$1.02M Buy
19,922
+1,216
+7% +$52.5K ﹤0.01% 1303
2018
Q4 		$692K Sell
18,706
-143
-0.8% -$5.16K ﹤0.01% 1484
2018
Q3 		$708K Buy
18,849
+1,041
+6% +$38.3K ﹤0.01% 1674
2018
Q2 		$704K Sell
17,808
-2,495
-12% -$79.2K ﹤0.01% 1609
2018
Q1 		$523K Buy
20,303
+13,231
+187% +$396K ﹤0.01% 1693
2017
Q4 		$191K Buy
7,072
+366
+5% +$10.1K ﹤0.01% 2349
2017
Q3 		$251K Buy
6,706
+501
+8% +$15.2K ﹤0.01% 2159
2017
Q2 		$155K Buy
+6,205
New +$143K ﹤0.01% 2438

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

American International Group's BHVN Position: Q4 2022 in Review

American International Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 29,981 shares — an estimated $4.53M sold.

American International Group first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $4.53M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • American International Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • American International Group sold 29,981 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $4.53M.
  • American International Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • American International Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $4.53M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on American International Group's 13F filing for Q4 2022, filed 10 Feb 2023.